ENT Devices Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 28 | Published : January 2018 | SKU CODE : 2650 | Format :

ENT devices are used for diagnosis, surgery and treatment of any kind of diseases related to ear, nose and throat and thereby correct the problems related to hearing, snoring, smelling or speaking. Diseases can include hear loss, chronic ear disease, airway stenosis, airway tumors, cancer, feeding and swallowing disorders, mastoiditis, voice disorders (Dysphonia), sinusitis and others. Some of the popular ENT devices available in the market are endoscopes, hearing aids, hearing implants, handheld surgical instruments, balloon sinus dilation devices, CO2 lasers, image-guided surgery systems, ear tubes, and voice prosthesis devices.

The top five companies covered are Sonova Holdings AG, William Demant Holdings A/S, Medtronic plc, KARLSTORZ GmbH & Co and Stryker Corporation. Sonova Holdings AG was the largest company in the ENT devices market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The global ENT devices market was valued at around $90 billion in 2017. Asia Pacific was the largest region in the ENT devices market in 2017, accounting for nearly 35% of the market share. The USA was the largest country in the market in 2017, accounting for more than 21% market share.

Companies in the ENT device market are working towards constant innovation in design and technology to make these devices more user friendly and non-invasive. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid which is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time.

The ENT devices market is segmented into Hearing Aid Devices, Hearing Diagnostic Devices, ENT Surgical Devices, Nasal Splints, Hearing Implants and Voice Prosthesis Devices. Hearing Aids are devices designed and developed to improve hearing of people affected by hear loss. ENT Surgical Equipment segment includes devices used in ENT surgeries by surgeons and ENT specialists. Voice Prosthesis Devices are artificial devices provide the capability to speak in patients who have undergone laryngectomy (removal of larynx). Nasal Splints are devices meant specifically to fit into or on the nose for providing support following nasal surgeries. ENT Surgical Equipment segment includes devices used in ENT surgeries by surgeons and ENT specialists.

Next-gen Biologics- The Way Forward

The Telemedicine Technology Market Will More Than Double by 2022

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)